Home/Lokon Pharma/Gustav Ullenhag
GU

Gustav Ullenhag

Principal Investigator (LOKON003)

Lokon Pharma

Therapeutic Areas

Lokon Pharma Pipeline

DrugIndicationPhase
LOAd703 (LOKON001)Pancreatic CancerPhase 1/2
LOAd703 (LOKON002)Pancreatic, Biliary, Ovarian, Colorectal CancerPhase 1/2
LOAd703 (LOKON003)Malignant MelanomaPhase 1/2